Printed NCCN Guidelines for Patients
® available for order on Amazon.com for Breast (Stages 0 - IV), Colon, and Pancreatic Cancers; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; and Soft Tissue Sarcoma. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation®, announces the availability of printed versions of the NCCN Guidelines for Patients® for order on Amazon.com for the following cancer types: Breast (Stages 0 - IV), C... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 12, 2014 Category: Cancer & Oncology Source Type: news

"New Test Developed at Dana-Farber/Brigham and Women's Cancer Center Speeds Treatment Decisions for Blood Cancer Patients," Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center
In a major advance in the care of these patients, physicians at Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) have begun using Rapid Heme Panel, a high-tech genetic test that provides, within a matter of days, an unprecedented amount of critical information to aid the choice of treatment. Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 11, 2014 Category: Cancer & Oncology Source Type: news

"Cancer-Killing Virus Plus Chemotherapy Drug Might Treat Recurrent Ovarian Cancer," The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute
In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent. A new study suggests that a cancer-killing virus combined with a chemotherapy drug might safely and effectively treat advanced or recurrent forms of the disease. The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 11, 2014 Category: Cancer & Oncology Source Type: news

"Mayo Clinic Researchers Identify First Steps in Formation of Pancreatic Cancer," Mayo Clinic Cancer Center
Researchers at Mayo Clinic's campus in Jacksonville say they have identified first steps in the origin of pancreatic cancer and that their findings suggest preventive strategies to explore. Mayo Clinic Cancer Center is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 10, 2014 Category: Cancer & Oncology Source Type: news

"Colorectal Cancer Rates Increasing for U.S. Adults Under 50,"
While rates of colorectal cancer (CRC) have fallen among older Americans, cases among adults aged 20 to 49 are rising and expected to continue to do so, according to research from The University of Texas MD Anderson Cancer Center published online Nov. 5 in JAMA Surgery. The University of Texas MD Anderson Cancer Center is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 10, 2014 Category: Cancer & Oncology Source Type: news

"Promising Prognostic Biomarker Candidates for Ovarian Cancer Uncovered by Roswell Park Team," Roswell Park Cancer Institute
Cancer researchers at Roswell Park Cancer Institute (RPCI) have identified two independent classes of novel candidate prognostic markers for ovarian cancer, advancing efforts to develop targeted therapies for the disease. The findings resulted from two separate studies published in the peer-reviewed journal PLoS ONE and based on data from The Cancer Genome Atlas (TCGA), the world's largest public database on gene expression in different tumor types. Roswell Park Cancer Institute is one of the... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 10, 2014 Category: Cancer & Oncology Source Type: news

"MD Anderson’s David M. Gershenson, MD, Receives IGCS’s Award for Excellence in Gynecologic Oncology," The University of Texas MD Anderson Cancer Center
For his myriad clinical, organizational and scientific accomplishments in the field of gynecologic oncology and the health and well-being of women, David M. Gershenson, M.D. has been recognized with the International Gynecology Cancer Society's (IGCS) Award of Excellence. The University of Texas MD Anderson Cancer Center is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 10, 2014 Category: Cancer & Oncology Source Type: news

"Yale Study: Medicare Costs for Breast Cancer Screenings Soar, but Benefits Remain Unclear,"
The cost of Medicare-funded breast cancer screenings jumped 44 percent from $666 million to $962 million from 2001 to 2009, yet those added millions did not improve early detection rates among the 65 and older Medicare population, according to a Yale School of Medicine study published recently in the Journal of the National Cancer Institute. Yale Cancer Center/Smilow Cancer Hospital is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 9, 2014 Category: Cancer & Oncology Source Type: news

"As U.S. Cases of Skin Cancer Rise, Costs Skyrocket, Too," Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Rising rates of skin cancer in the U.S. are taking a toll not only on the nation's health, but on its wallet as well, a new federal study finds. Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 9, 2014 Category: Cancer & Oncology Source Type: news

"Researchers Take New Approach to Stop 'Most Wanted' Cancer Protein," Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center
Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found a way to defeat one of the most tantalizing yet elusive target proteins in cancer cells - employing a strategy that turns the protein's own molecular machinations against it. Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 7, 2014 Category: Cancer & Oncology Source Type: news

"Dr. Candace Johnson Named Cancer Center Director at Roswell Park Cancer Institute," Roswell Park Cancer Institute
Candace S. Johnson, PhD, has been promoted to Cancer Center Director at Roswell Park Cancer Institute (RPCI), the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. In this new role with the Institute, she will manage the Institute's Cancer Center Support Grant (CCSG) from the NCI as Principal Investigator and will oversee faculty recruitment and allocation of resources including space, personnel and institutional funds. Roswell Park Cancer Institute is... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 6, 2014 Category: Cancer & Oncology Source Type: news

NCCN Chemotherapy Order Templates to be Integrated into Epic ’s Electronic Health Record
The integration of the NCCN Chemotherapy Order Templates (NCCN Templates ®) into Epic allows for access to evidence-based treatment protocols based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) is working with Epic to integrate the NCCN Chemotherapy Order Templates ( NCCN Templates®) into Epic's Beacon Oncology Information System as electronic chemotherapy protocols for use by health care provid... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - October 20, 2014 Category: Cancer & Oncology Source Type: news

NCCN Chemotherapy Order Templates to be Integrated into Epic’s Electronic Health Record
The integration of the NCCN Chemotherapy Order Templates (NCCN Templates®) into Epic allows for access to evidence-based treatment protocols based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) is working with Epic to integrate the NCCN Chemotherapy Order Templates (NCCN Templates®) into Epic's Beacon Oncology Information System as electronic chemotherapy protocols for use by health care provid... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - October 20, 2014 Category: Cancer & Oncology Source Type: news

Looking Back: 20 Years of Colorectal Cancer Treatment Breakthroughs Improve Survival, Advance Evidence-Based Choices
NCCN has published the 20th annual editions of the NCCN Guidelines® for Colon and Rectal Cancers, two of the original eight NCCN Guidelines published in November 1996. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) has published the 20th annual editions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Colon and Rectal Cancers, two of the eight original NCCN Guidelines® published in November 1996. 'A lot has changed in the treatment of co... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - October 11, 2014 Category: Cancer & Oncology Source Type: news

Oncology Experts and Patient Advocates to Deliberate Patient Concerns: Big Data, Access to Quality Cancer Care, and Palliative Care
On November 3, 2014, NCCN will host its annual Patient Advocacy Summit: Patient Concerns in 2014 - Big Data, Access, and Palliative Care, at The National Press Club in Washington, DC. FORT WASHINGTON, PA - On November 3, 2014, as part of its Oncology Policy Program, the National Comprehensive Cancer Network® (NCCN®) will host its 5th Annual Patient Advocacy Summit: Patient Concerns in 2014 - Big Data, Access, and Palliative Care, at The National Press Club in Washington, DC. Patients toda... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - October 4, 2014 Category: Cancer & Oncology Source Type: news